International Isotopes (INIS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : International Isotopes (INIS)

INIS 0.0620

-6.1%

3:17 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mantle7 who wrote (28)	3/24/1998 10:42:00 AM
From: Richard Belanger	Read Replies (1) of 81

I own both NASI and INIS, but for different reasons. NASI is a niche player that will do well in the seed business. INIS, on the other hand, is developing an infrastructure that will allow it to produce many isotopes for many applications, cheaper than the next guy. Remember, the driving force behind the company's formation was production of Mo-99/Tc-99m, which is used more frequently than all other medical isotopes combined. All Mo-99/Tc-99m used in the U.S. is currently imported. The seed business is just one more extension of their production capability. That said, I did lighten up on INIS at 32.25; I simply believe the stock had gotten a little bit ahead of itself. I am looking to buy those shares back in mid-low twenties. If I don't get that chance, I'll pay more. Rich

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next